Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin, vol.68, pp.394-424, 2018. ,
, CA Cancer J. Clin, vol.68, pp.7-30, 2018.
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma, Clin. Cancer Res, vol.14, pp.5731-5734, 2008. ,
Ras oncogenes: split personalities, Nat. Rev. Mol. Cell Biol, vol.9, pp.517-531, 2008. ,
KRAS mutations: an old oncogene becomes a new predictive biomarker, J. Mol. Diagn, vol.10, pp.493-495, 2008. ,
KRAS mutation testing in metastatic colorectal cancer, World J. Gastroenterol, vol.18, pp.5171-5180, 2012. ,
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas, Mod. Pathol, vol.27, pp.262-270, 2014. ,
Drugging the undruggable RAS: Mission possible?, Nat. Rev. Drug Discov, vol.13, pp.828-851, 2014. ,
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism, Cell, vol.149, pp.656-670, 2012. ,
Regulation of RAS oncogenicity by acetylation, vol.109, pp.10843-10848, 2012. ,
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity, vol.109, pp.5299-5304, 2012. ,
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities, Eur. J. Cancer, vol.54, pp.75-83, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01278606
Therapeutic strategies to target RAS-mutant cancers, Nat. Rev. Clin. Oncol, vol.15, pp.709-720, 2018. ,
Identification of a new potent inhibitor targeting KRAS in non-small cell lung cancer cells, Front. Pharmacol, vol.8, p.823, 2017. ,
Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation, Angew. Chem, vol.51, pp.6140-6143, 2012. ,
Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity, Cell Death. Dis, vol.9, p.216, 2018. ,
Targeting RAS membrane association: back to the future for anti-RAS drug discovery?, Clin. Cancer Res, vol.21, pp.1819-1827, 2015. ,
KRAS-driven metabolic rewiring reveals novel actionable targets in cancer, Front. Oncol, vol.9, p.848, 2019. ,
Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth, Genome Res, vol.28, pp.374-382, 2018. ,
Re-evaluation of G-quadruplex propensity with G4Hunter, Nucleic Acids Res, vol.44, pp.1746-1759, 2016. ,
A toolbox for predicting g-quadruplex formation and stability, J. Nucleic Acids, p.564946, 2010. ,
Overview of formation of G-quadruplex structures, Curr. Protoc. Nucleic Acid Chem, 2010. ,
Predicting and understanding the stability of G-quadruplexes, 2009. ,
, Bioinformatics, vol.25, pp.374-382
G-quadruplex conformation and dynamics are determined by loop length and sequence, Nucleic Acids Res, vol.42, pp.8106-8114, 2014. ,
Explaining the varied glycosidic conformational, G-tract length and sequence preferences for anti-parallel G-quadruplexes, Nucleic Acids Res, vol.39, pp.4499-4512, 2011. ,
An investigation of G-quadruplex structural polymorphism in the human telomere using a combined approach of hydrodynamic bead modeling and molecular dynamics simulation, J. Phys. Chem. B, vol.118, pp.5390-5405, 2014. ,
Polymorphism of human telomeric quadruplex structures, Biochimie, vol.90, pp.1172-1183, 2008. ,
DNA secondary structures: stability and function of G-quadruplex structures, Nat. Rev. Genet, vol.13, pp.770-780, 2012. ,
G-quadruplex structures: in vivo evidence and function, Trends Cell Biol, vol.19, pp.414-422, 2009. ,
DNA G-quadruplex: structure, function and human disease, FEBS J, vol.277, p.3451, 2010. ,
HMGB1 binds to the KRAS promoter G-quadruplex: a new player in oncogene transcriptional regulation?, Chem. Commun, vol.54, pp.9442-9445, 2018. ,
Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: a molecular mechanism involving G4 DNA, Biochim. Biophys. Acta Gen. Subj, vol.1861, pp.1389-1398, 2017. ,
Fluorescent light-up acridine orange derivatives bind and stabilize KRAS-22RT G-quadruplex, Biochimie, vol.144, pp.144-152, 2018. ,
The structures of quadruplex nucleic acids and their drug complexes, Curr. Opin. Struct. Biol, vol.19, pp.239-250, 2009. ,
Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells, J. Med. Chem, vol.52, pp.564-568, 2009. ,
Interaction of KRAS G-quadruplex with natural polyphenols: a spectroscopic analysis with molecular modeling, Int. J. Biol. Macromol, vol.89, pp.228-237, 2016. ,
, Nucleic Acids Research, vol.48, issue.16, p.9345, 2020.
Through-bond correlation of imino and aromatic resonances in 13C-, 15N-labeled RNA via heteronuclear TOCSY, J. Biomol. NMR, vol.7, pp.83-87, 1996. ,
HCCCH experiment for through-bond correlation of thymine resonances in 13C-labeled DNA oligonucleotides, J. Magn. Reson, vol.137, pp.345-349, 1999. ,
Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta crystallog D, Biol Crystallogr, vol.54, pp.905-921, 1998. ,
Version 1.2 of the crystallography and NMR system, Nat. Protoc, vol.2, pp.2728-2733, 2007. ,
Circular dichroism of quadruplex structures, Top. Curr. Chem, vol.330, pp.67-86, 2013. ,
Circular dichroism spectroscopy of DNA: from duplexes to quadruplexes, Chirality, vol.24, pp.691-698, 2012. ,
NMR methods for studying quadruplex nucleic acids, Methods, vol.43, pp.264-277, 2007. ,
Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins, Nucleic Acids Res, vol.36, pp.3765-3780, 2008. ,
G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription, Nucleic Acids Res, vol.34, pp.2536-2549, 2006. ,
Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter, Nat. Chem. Biol, vol.1, pp.167-173, 2005. ,
, , 2017.
Quadruplex surveillance in BCL-2 gene: a promising therapeutic intervention in cancer treatment, Drug Discov. Today, vol.22, pp.1165-1186 ,
Oncogene expression modulation in cancer cell lines by DNA G-Quadruplex-Interactive small molecules, Curr. Med. Chem, vol.24, pp.4873-4904, 2017. ,
Recent progress of targeted G-Quadruplex-Preferred ligands toward cancer therapy, Molecules, p.24, 2019. ,
, , 2016.
, G-quadruplex structures mark human regulatory chromatin, Nat. Genet, vol.48, pp.1267-1272
Primer extension reactions as a tool to uncover folding motifs within complex G-rich sequences: analysis of the human KRAS NHE, Chem. Commun. (Camb.), vol.47, pp.4965-4967, 2011. ,
KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G-quadruplex units, Nucleic Acids Res, vol.44, pp.917-925, 2016. ,
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice, Nucleic Acids Res, vol.41, pp.4049-4064, 2013. ,
Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter, Nat. Chem. Biol, vol.1, pp.67-173, 2005. ,